VelosBio (Series A)

Funding Details
Awarder
Inbox
Date Award
October 01, 2018
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$58,000,000

Company Info
Founding Year
2017
Organizations Involved
Arix Bioscience, Decheng Capital, Pappas Capital, Sofinnova Ventures, Takeda Ventures
Company Description
VelosBio is a next-generation oncology company, developing novel antibody-drug conjugates to treat haematological cancers.
Market
Cancer treatment
Location
San Diego, California, United States
Coinvestors
Chiesi Ventures, Decheng Capital, Pappas Ventures, Sofinnova Ventures, Takeda Pharmaceutical Company

Links